First-line treatment for advanced pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.

Oberstein, Paul E; Saif, Muhammad Wasif

Oberstein, Paul E; Saif, Muhammad Wasif.

Affiliation

Oberstein PE; Columbia University College of Physicians and Surgeons at New York Presbyterian Hospital. New York, NY, USA.

JOP ; 12(2): 96-100, 2011 Mar 09.

Article in En | MEDLINE | ID: mdl-21386629

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Pancreatic Neoplasms/drug therapy; Benzenesulfonates/administration & dosage; Capecitabine; Clinical Trials as Topic; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Erlotinib Hydrochloride; Fluorouracil/administration & dosage; Fluorouracil/analogs & derivatives; Humans; Lapatinib; Medicine, Chinese Traditional; Niacinamide/analogs & derivatives; Pancreatic Neoplasms/pathology; Pancreatic Neoplasms/therapy; Phenylurea Compounds; Pyridines/administration & dosage; Quinazolines/administration & dosage; Sorafenib; Treatment Outcome; Gemcitabine

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Diagnostic_studies Limits: Humans Language: En Journal: JOP Journal subject: ENDOCRINOLOGIA / GASTROENTEROLOGIA Year: 2011 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links